Sridharan, Vishwajith
Margalit, Danielle N
Lynch, Stephanie A
Severgnini, Mariano
Zhou, Jun
Chau, Nicole G
Rabinowits, Guilherme
Lorch, Jochen H
Hammerman, Peter S
Hodi, F Stephen
Haddad, Robert I
Tishler, Roy B
Schoenfeld, Jonathan D
Article History
Received: 28 February 2016
Revised: 1 May 2016
Accepted: 9 May 2016
First Online: 5 July 2016
Competing interests
: RIH reports research support from BI, Merck, Bristol-Myers Squibb, ASTRA ZENECA, and CELGENE; and provides consulting for BMS, MERCK, AstraZeneca, and BI. FSH reports grant support from Bristol Myers Squibb, personal fees from Novartis, personal fees and other support from Merck, and other support from Genentech. In addition, FSH reports pending patents related to tumour antigens and uses thereof (patent number 7250291). The remaining authors declare no conflict of interest.